ArticleCancers2021

On-Treatment Albumin-Bilirubin Grade: Predictor of Response and Outcome of Sorafenib-Regorafenib Sequential Therapy in Patients with Unresectable Hepatocellular Carcinoma.

Hung-Wei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.